# Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)

> **NCT01270724** · PHASE2 · COMPLETED · sponsor: **Nationwide Children's Hospital** · enrollment: 10 (actual)

## Conditions studied

- CNS Germ Cell Tumor

## Interventions

- **DRUG:** Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx).

## Key facts

- **NCT ID:** NCT01270724
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2019-10-23
- **Final completion:** 2019-12-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01270724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01270724, "Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01270724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*